BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 7408665)

  • 21. The effect of pentoxifylline in septic shock--new pharmacologic aspects of an established drug.
    Schönharting MM; Schade UF
    J Med; 1989; 20(1):97-105. PubMed ID: 2651550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.
    Ward A; Clissold SP
    Drugs; 1987 Jul; 34(1):50-97. PubMed ID: 3308412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentoxifylline for sickle-cell disease.
    Sherer JT; Glover PH
    Ann Pharmacother; 2000 Sep; 34(9):1070-4. PubMed ID: 10981255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular complications and risk of death in sickle-cell disease.
    Gladwin MT
    Lancet; 2016 Jun; 387(10037):2565-74. PubMed ID: 27353687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiopulmonary complications in sickle cell anemia].
    Rojas-Jiménez S; Lopera-Valle J; Yabur-Espítia M
    Arch Cardiol Mex; 2013; 83(4):289-94. PubMed ID: 24215682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The critically ill child: sickle cell disease crises and their management.
    Pearson HA; Diamond LK
    Pediatrics; 1971 Oct; 48(4):629-35. PubMed ID: 4940005
    [No Abstract]   [Full Text] [Related]  

  • 28. Co-existing sickle cell anaemia and inflammatory bowel disease: case report and review of the literature.
    Adepoju AA; Akere A; Ogun GO; Ogunbosi BO; Asinobi AO; Bello O; Orimadegun AE; Allen S; Akinyinka OO
    Paediatr Int Child Health; 2022 Feb; 42(1):29-35. PubMed ID: 34474658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleiotropic effects of intravascular haemolysis on vascular homeostasis.
    Kato GJ; Taylor JG
    Br J Haematol; 2010 Mar; 148(5):690-701. PubMed ID: 19958359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improvement of blood viscosity in sickle-cell anaemia by pentoxifylline (author's transl)].
    Keller F; Leonhardt H
    Dtsch Med Wochenschr; 1980 Jun; 105(25):898-900. PubMed ID: 7408665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Stiff red cell syndrome". A review of the treatment of sickle cell disease with pentoxifylline.
    Ambrus JL; Reddington TM; Meky NN; Conway J
    J Med; 1993; 24(1):1-9. PubMed ID: 8501400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?].
    Mariéthoz S; Pittet B; Loutan L; Humbert J; Montandon D
    Ann Chir Plast Esthet; 1999 Feb; 44(1):81-8. PubMed ID: 10188298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.